McNeil Products

McNeil Products is a leading consumer healthcare company and a primary subsidiary of Kenvue, the independent consumer health entity spun off from Johnson & Johnson in 2023. The company manages an iconic portfolio of over-the-counter (OTC) medications, including Tylenol, Motrin, Zyrtec, and Benadryl. Its products address a wide range of therapeutic needs such as pain relief, fever reduction, allergy management, and digestive health. McNeil is recognized for its commitment to science-based self-care and has a long history of innovation in drug delivery and safety packaging. Operating globally, the company maintains significant corporate and manufacturing presences in the United States and the United Kingdom. As part of Kenvue, McNeil continues to focus on expanding its reach in the global retail healthcare market.